QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
Free Trial

Tarsus Pharmaceuticals (TARS) Insider Trading & Ownership

→ Start loving Mondays like this (From DTI) (Ad)
Free tars Stock Alerts
$33.00
+0.15 (+0.46%)
(As of 01:03 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.54%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$178,660.80
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$5.80 M
Get TARS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TARS Insider Buying and Selling by Quarter

Ad Paradigm Press
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Click here to find out that this 8,788% cryptocurrency is.

Tarsus Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024Aziz MottiwalaInsiderSell4,766$30.60$145,839.60  
3/18/2024Bobak R AzamianCEOSell10,415$30.60$318,699.00  
3/18/2024Bryan WahlGeneral CounselSell4,436$30.60$135,741.60  
3/18/2024Seshadri NeervannanCOOSell4,879$30.60$149,297.40  
12/27/2023Bobak R AzamianCEOSell8,000$20.22$161,760.00  
12/20/2023Bobak R AzamianCEOSell40,000$20.27$810,800.00  
12/20/2023Jose M TrevejoInsiderSell2,252$20.00$45,040.00  
12/15/2023Andrew D GoldbergDirectorBuy1,000$18.96$18,960.00  
11/30/2023Bryan WahlGeneral CounselSell8,356$16.31$136,286.36  
11/30/2023Dianne C WhitfieldInsiderSell8,355$16.31$136,270.05  
10/18/2023Bobak R AzamianCEOSell8,000$13.24$105,920.00  
10/5/2023Jose M TrevejoInsiderSell1,604$18.00$28,872.00  
9/20/2023Bobak R AzamianCEOSell8,000$17.21$137,680.00  
8/23/2023Bobak R AzamianCEOSell8,000$17.23$137,840.00  
8/15/2023Elizabeth Yeu LinDirectorBuy9,506$16.80$159,700.80  
7/19/2023Aziz MottiwalaInsiderSell2,400$20.05$48,120.00  
7/19/2023Bobak R AzamianCEOSell103,900$20.01$2,079,039.00  
7/12/2023Bobak R AzamianCEOSell9,000$17.35$156,150.00  
6/21/2023Bobak R AzamianCEOSell8,000$18.63$149,040.00  
6/14/2023Bobak R AzamianCEOSell9,000$18.58$167,220.00  
6/8/2023Aziz MottiwalaInsiderSell100$20.00$2,000.00  
6/8/2023Bobak R AzamianCEOSell3,100$20.01$62,031.00  
6/6/2023Aziz MottiwalaInsiderSell2,143$18.61$39,881.23  
5/17/2023Bobak R AzamianCEOSell8,000$15.90$127,200.00  
5/10/2023Bobak R AzamianCEOSell9,000$16.80$151,200.00  
5/1/2023Bobak R AzamianCEOSell5,841$15.10$88,199.10  
4/28/2023Bobak R AzamianCEOSell4,278$15.13$64,726.14  
4/21/2023Bobak R AzamianCEOSell2,311$15.03$34,734.33  
4/20/2023Leonard M GreensteinCFOSell5,000$14.02$70,100.00  
4/19/2023Bobak R AzamianCEOSell8,000$13.60$108,800.00  
(Data available from 1/1/2013 forward)

TARS Insider Trading Activity - Frequently Asked Questions

Who is on Tarsus Pharmaceuticals's Insider Roster?

The list of insiders at Tarsus Pharmaceuticals includes Andrew D Goldberg, Aziz Mottiwala, Bobak R Azamian, Bryan Wahl, Dianne C Whitfield, Elizabeth Yeu Lin, Jose M Trevejo, Leonard M Greenstein, Mark J Holdbrook, Michael Ackermann, Rtw Investments, Lp, Seshadri Neervannan, and Vivo Capital Ix, Llc. Learn more on insiders at TARS.

What percentage of Tarsus Pharmaceuticals stock is owned by insiders?

11.54% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings.

Which Tarsus Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased TARS shares in the last 24 months: Andrew D Goldberg ($18,960.00), Elizabeth Yeu Lin ($456,308.80), and Michael Ackermann ($1,350,000.00).

How much insider buying is happening at Tarsus Pharmaceuticals?

Insiders have purchased a total of 128,906 TARS shares in the last 24 months for a total of $1,825,268.80 bought.

Which Tarsus Pharmaceuticals insiders have been selling company stock?

The following insiders have sold TARS shares in the last 24 months: Aziz Mottiwala ($357,346.87), Bobak R Azamian ($6,387,921.94), Bryan Wahl ($305,087.62), Dianne C Whitfield ($179,479.24), Jose M Trevejo ($87,281.86), Leonard M Greenstein ($537,152.33), Mark J Holdbrook ($5,008.19), Seshadri Neervannan ($163,674.27), and Vivo Capital Ix, Llc ($885,022.46).

How much insider selling is happening at Tarsus Pharmaceuticals?

Insiders have sold a total of 503,145 Tarsus Pharmaceuticals shares in the last 24 months for a total of $8,907,974.78 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:TARS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
My biggest AI fear
Paradigm Press